Topical zinc oxide in pressure ulcer

Not Applicable

Recruiting

Conditions: ?Stage I or II pressure ulcers.
Decubitus ulcer and pressure area

Registration Number: IRCT20221023056276N1

Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

Patients with baseline stage I or II pressure ulcers according to the 2-digit Stirling pressure ulcer severity scale
Patients hospitalized in Shahid Beheshti hospital, Hamedan

Exclusion Criteria

Patients with baseline stage III or IV pressure ulcers
Patients with acute confirmed infection
Patients with suspected ulcer Infection
Patients with hypersensitivity reactions to our topical Formulations
Patients who were unwilling to enter the study

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The percentage of wound size change on the 7th and 14th days of the intervention. Timepoint: Measurement of wound surface area at the beginning of the study (before the start of the intervention) and 7 and 14 days after starting the intervention. Method of measurement: Imaging the surface of the wound with a camera and then calculating its area in ImageJ software.

Secondary Outcome Measures

Name	Time	Method
The number of patients without erythema around the wound. Timepoint: At the beginning of the study (before the start of the intervention) and 7 and 14 days after starting the intervention. Method of measurement: Visual observation.;The number of cases with complete wound healing. Timepoint: Days 7 and 14 after the start of the intervention. Method of measurement: Measuring the surface area of the wound at the beginning of the study (before the start of the intervention) and 7 and 14 days after its start and observing cases of more than 90% reduction in the size of the wound compared to the dimensions measured at the beginning of the study.